ArticleCell & bioscience2019

Preclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors.

Xuechao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.